Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Brain Res ; 1407: 90-6, 2011 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-21741032

RESUMEN

We characterized the effect of acute ischemic stroke on the activation of the hypothalamic-pituitary-adrenal (HPA) axis and evaluated the role of glucocorticoids (GC) in the clinical outcome following ischemic stroke. Male spontaneous hypertensive rats underwent permanent middle cerebral artery occlusion (PMCAO) and developed a cortical infarct. At 4h post-PMCAO or sham operation, serum levels of ACTH and corticosterone (CS) were elevated 5 and 4 fold respectively as compared to controls and then returned to basal levels at 24h post surgery. In these experimental groups we found also a significant depletion of median eminence (ME)-CRH(41). In adrenalectomized (Adx) rats that underwent PMCAO the degree of motor disability and infarct volume was similar to that of intact rats. Administration of dexamethasone (Dex) to Adx-PMCAO rats significantly improved the motor disability and decreased the infarct volume. However, in sham-Adx with PMCAO, Dex had no effect on these two parameters. In rats with PMCAO or sham-PMCAO, brain production of PGE(2) was significantly increased. This effect was further enhanced in Adx-PMCAO rats and significantly inhibited by Dex. In conclusion, activation of the HPA axis following PMCAO is due to stress induced by surgery. This activation is mediated by hypothalamic CRH(41). Absence of endogenous GC or administration of Dex in naïve rats does not alter motor and pathological parameters in the acute stage following PMCAO. In contrast, administration of Dex significantly improved the outcome following cerebral ischemia in Adx rats which may be due to increased glucocorticoid receptors. Brain production of PGE(2) does not play an important role in the pathophysiology of the acute phase of cerebral ischemia.


Asunto(s)
Corteza Suprarrenal/fisiología , Isquemia Encefálica/fisiopatología , Glucocorticoides/fisiología , Glucocorticoides/uso terapéutico , Infarto de la Arteria Cerebral Media/tratamiento farmacológico , Accidente Cerebrovascular/fisiopatología , Adrenalectomía , Hormona Adrenocorticotrópica/sangre , Animales , Antiinflamatorios/uso terapéutico , Isquemia Encefálica/complicaciones , Corticosterona/sangre , Hormona Liberadora de Corticotropina/metabolismo , Dexametasona/uso terapéutico , Dinoprostona/metabolismo , Sistema Hipotálamo-Hipofisario/fisiología , Hipotálamo/metabolismo , Infarto de la Arteria Cerebral Media/etiología , Infarto de la Arteria Cerebral Media/fisiopatología , Cojera Animal/etiología , Cojera Animal/patología , Masculino , Eminencia Media/fisiología , Fragmentos de Péptidos/metabolismo , Ratas , Ratas Endogámicas SHR , Receptores de Glucocorticoides/efectos de los fármacos , Receptores de Glucocorticoides/fisiología , Accidente Cerebrovascular/etiología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA